PT-141 (Bremelanotide) 10mg
€20.00
- Description
- Benefits
- Risks
- Additional information
- Research
Description
PT-141 (Bremelanotide) is a synthetic peptide derived from the melanocortin peptide family, studied in laboratory environments for its role in central nervous system signalling, melanocortin receptor activation, and neuroendocrine pathway research.
Unlike peptides that act on vascular or peripheral systems, PT-141 is primarily investigated for its interaction with melanocortin receptors (MC receptors) within the central nervous system, making it a key compound in studies focused on neural signalling, behavioural pathways, and hormone-related brain activity.
In controlled research settings, PT-141 is explored for its effects on neurotransmitter pathways, hormonal signalling, and central regulatory systems, particularly those linked to brain-mediated physiological responses.
Across Ireland and Europe, PT-141 is commonly studied in areas such as:
- Melanocortin receptor (MC receptor) signalling
- Central nervous system and neuroendocrine research
- Hormone-related brain pathway studies
- Behavioural and neurological signalling research
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – PT-141 (Bremelanotide)
| Specification | Details |
|---|---|
| Product Name | PT-141 (Bremelanotide) |
| Compound Type | Synthetic melanocortin peptide |
| Functional Class | Melanocortin receptor agonist |
| Mechanism of Action | Activates MC receptors in the central nervous system |
| Biological Targets | Melanocortin receptors (MC3R, MC4R), CNS pathways |
| Origin | Derived from α-MSH analogues |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Researched Benefits & Focus Areas – PT-141 (Bremelanotide)
1. Melanocortin Receptor Activation
PT-141 has been studied for:
- Activation of melanocortin receptors (MC3R, MC4R)
- Investigation of central receptor signalling pathways
- Analysis of peptide-receptor interactions in neural systems
Reference basis: Derived from neuropharmacology research examining melanocortin receptor agonists and central signalling pathways.
2. Central Nervous System Signalling
Research has explored:
- Interaction with neurotransmitter pathways
- Influence on brain-mediated signalling mechanisms
- Role in neuroendocrine system regulation
Reference basis: Based on studies investigating central nervous system peptide signalling and neuroendocrine interactions.
3. Hormonal & Behavioural Pathway Research
PT-141 is commonly studied for:
- Regulation of hormone-driven neural pathways
- Investigation of behavioural response signalling
- Interaction with brain-hormone communication systems
Reference basis: Supported by research into melanocortin peptides and behavioural neuroendocrinology.
4. Neuroendocrine System Modulation
- Studied for its role in brain–endocrine system interaction
- Explored in central regulation of physiological processes
- Investigated for signal transduction within neural pathways
Reference basis: Derived from neuroendocrine research examining peptide signalling in the brain.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – PT-141 (Bremelanotide)
1. Central Nervous System Effects
- May significantly influence neural signalling pathways
- Potential for variable neurological responses in models
Reference basis: Based on studies examining melanocortin receptor activation in the brain.
2. Hormonal System Interaction
- May affect neuroendocrine signalling systems
- Potential for complex hormone–brain interaction effects
Reference basis: Derived from research into neuroendocrine regulation and peptide signalling.
3. Off-Target Receptor Activity
- Possible interaction with multiple melanocortin receptor subtypes
- Broad influence across central signalling pathways
Reference basis: Based on studies highlighting receptor distribution and peptide binding profiles.
4. Limited Long-Term Research
- Lack of extensive long-term data in research models
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of PT-141 research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS